富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/14 | 1,508 | 1,533 | 1,508 | 1,530 | +13 | +0.9% | 79,700 |
| 2025/01/10 | 1,540 | 1,541 | 1,507 | 1,517 | -43 | -2.8% | 95,900 |
| 2025/01/09 | 1,543 | 1,574 | 1,542 | 1,560 | +19 | +1.2% | 90,600 |
| 2025/01/08 | 1,570 | 1,575 | 1,534 | 1,541 | -22 | -1.4% | 88,500 |
| 2025/01/07 | 1,600 | 1,602 | 1,559 | 1,563 | -33 | -2.1% | 156,400 |
| 2025/01/06 | 1,604 | 1,606 | 1,596 | 1,596 | -3 | -0.2% | 82,200 |
| 2024/12/30 | 1,610 | 1,619 | 1,599 | 1,599 | -11 | -0.7% | 92,700 |
| 2024/12/27 | 1,581 | 1,615 | 1,581 | 1,610 | +29 | +1.8% | 137,300 |
| 2024/12/26 | 1,593 | 1,593 | 1,571 | 1,581 | -12 | -0.8% | 87,500 |
| 2024/12/25 | 1,613 | 1,613 | 1,574 | 1,593 | -18 | -1.1% | 95,800 |
| 2024/12/24 | 1,588 | 1,613 | 1,572 | 1,611 | +52 | +3.3% | 154,500 |
| 2024/12/23 | 1,547 | 1,569 | 1,538 | 1,559 | +10 | +0.6% | 91,600 |
| 2024/12/20 | 1,546 | 1,569 | 1,542 | 1,549 | +13 | +0.8% | 107,400 |
| 2024/12/19 | 1,514 | 1,558 | 1,510 | 1,536 | +4 | +0.3% | 82,300 |
| 2024/12/18 | 1,548 | 1,549 | 1,520 | 1,532 | -16 | -1% | 89,300 |
| 2024/12/17 | 1,552 | 1,557 | 1,541 | 1,548 | ±0 | ±0% | 124,000 |
| 2024/12/16 | 1,548 | 1,570 | 1,542 | 1,548 | +25 | +1.6% | 107,600 |
| 2024/12/13 | 1,528 | 1,537 | 1,510 | 1,523 | -5 | -0.3% | 103,100 |
| 2024/12/12 | 1,530 | 1,548 | 1,523 | 1,528 | -1 | -0.1% | 134,800 |
| 2024/12/11 | 1,527 | 1,542 | 1,520 | 1,529 | +4 | +0.3% | 79,500 |
| 2024/12/10 | 1,553 | 1,553 | 1,520 | 1,525 | -31 | -2% | 132,200 |
| 2024/12/09 | 1,560 | 1,572 | 1,551 | 1,556 | +6 | +0.4% | 88,100 |
| 2024/12/06 | 1,590 | 1,590 | 1,550 | 1,550 | -53 | -3.3% | 104,400 |
| 2024/12/05 | 1,590 | 1,611 | 1,587 | 1,603 | ±0 | ±0% | 161,900 |
| 2024/12/04 | 1,623 | 1,633 | 1,590 | 1,603 | -29 | -1.8% | 212,400 |
| 2024/12/03 | 1,634 | 1,640 | 1,595 | 1,632 | -3 | -0.2% | 170,300 |
| 2024/12/02 | 1,600 | 1,635 | 1,591 | 1,635 | +21 | +1.3% | 158,500 |
| 2024/11/29 | 1,598 | 1,643 | 1,590 | 1,614 | -8 | -0.5% | 284,200 |
| 2024/11/28 | 1,546 | 1,630 | 1,539 | 1,622 | +99 | +6.5% | 455,200 |
| 2024/11/27 | 1,573 | 1,573 | 1,500 | 1,523 | +16 | +1.1% | 362,600 |
| 2024/11/26 | 1,481 | 1,527 | 1,467 | 1,507 | +26 | +1.8% | 344,500 |
| 2024/11/25 | 1,465 | 1,488 | 1,456 | 1,481 | +23 | +1.6% | 136,100 |
| 2024/11/22 | 1,437 | 1,458 | 1,426 | 1,458 | +35 | +2.5% | 124,100 |
| 2024/11/21 | 1,428 | 1,437 | 1,410 | 1,423 | +3 | +0.2% | 65,300 |
| 2024/11/20 | 1,419 | 1,447 | 1,415 | 1,420 | +9 | +0.6% | 155,600 |
| 2024/11/19 | 1,365 | 1,421 | 1,365 | 1,411 | +41 | +3% | 182,100 |
| 2024/11/18 | 1,364 | 1,376 | 1,357 | 1,370 | +7 | +0.5% | 46,400 |
| 2024/11/15 | 1,390 | 1,391 | 1,339 | 1,363 | -9 | -0.7% | 69,300 |
| 2024/11/14 | 1,369 | 1,384 | 1,353 | 1,372 | +31 | +2.3% | 160,500 |
| 2024/11/13 | 1,296 | 1,361 | 1,290 | 1,341 | +16 | +1.2% | 228,300 |
| 2024/11/12 | 1,300 | 1,338 | 1,300 | 1,325 | +33 | +2.6% | 106,200 |
| 2024/11/11 | 1,299 | 1,303 | 1,283 | 1,292 | -1 | -0.1% | 78,500 |
| 2024/11/08 | 1,305 | 1,310 | 1,286 | 1,293 | -12 | -0.9% | 45,300 |
| 2024/11/07 | 1,295 | 1,324 | 1,295 | 1,305 | +12 | +0.9% | 56,400 |
| 2024/11/06 | 1,299 | 1,308 | 1,292 | 1,293 | +4 | +0.3% | 54,700 |
| 2024/11/05 | 1,301 | 1,302 | 1,286 | 1,289 | -3 | -0.2% | 37,000 |
| 2024/11/01 | 1,302 | 1,316 | 1,290 | 1,292 | -25 | -1.9% | 37,600 |
| 2024/10/31 | 1,314 | 1,324 | 1,302 | 1,317 | -2 | -0.2% | 41,200 |
| 2024/10/30 | 1,312 | 1,337 | 1,312 | 1,319 | +8 | +0.6% | 104,300 |
| 2024/10/29 | 1,313 | 1,320 | 1,300 | 1,311 | -1 | -0.1% | 46,000 |
151～
200
件表示中 / 7021件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 147,000円 | +15.7% | +5.3% | 3.10% | 10.64倍 | 0.79倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| 生化学 | 67,400円 | -9.6% | -30.2% | 4.45% | 27.27倍 | 0.50倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ダイト | 127,100円 | +3.7% | +10.9% | 3.15% | 16.57倍 | 0.73倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ミズホメディ | 158,000円 | -20.7% | -41.2% | 6.01% | 13.47倍 | 1.75倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| アンジェス | 8,300円 | +110.0% | - | 0.00% | - | 9.05倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
市場注目の銘柄
チャート関連のコラム
